MARKET

BCTX

BCTX

Briacell Therapeutics Corp
NASDAQ
4.180
+0.010
+0.24%
After Hours: 4.160 -0.02 -0.48% 19:21 02/06 EST
OPEN
4.130
PREV CLOSE
4.170
HIGH
4.235
LOW
4.050
VOLUME
195.88K
TURNOVER
--
52 WEEK HIGH
98.20
52 WEEK LOW
4.050
MARKET CAP
25.96M
P/E (TTM)
-0.0784
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BCTX last week (0126-0130)?
Weekly Report · 5d ago
BriaCell Imaging Data Show Tumor Regression and Immune Activation in Metastatic Breast Cancer Trial
TipRanks · 01/28 13:25
BriaCell says patient images show regression, resolution of metastsized tumors
TipRanks · 01/28 12:40
BriaCell Therapeutics Reports Tumor Regression in Phase 2 Study of Bria-IMT for Metastatic Breast Cancer
Reuters · 01/28 12:30
BRIACELL PATIENTS’ IMAGES SHOW REGRESSION AND RESOLUTION OF METASTASIZED TUMORS AND IMMUNE ACTIVATION
Reuters · 01/28 12:30
BriaCell Reports Extended Survival in Phase 2 Metastatic Breast Cancer Trial
Reuters · 01/27 17:05
BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer
TipRanks · 01/27 12:41
BriaCell Therapeutics Announces Data From Phase 2 Trial Evaluating Participants Surpassing Expected Benchmarks For Metastatic Breast Cancer
Benzinga · 01/27 12:37
More
About BCTX
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTX stock methods without spending real money on the virtual paper trading platform.